
BTAI
US listing · $2.3M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · -4.1% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 13, 2026 | After the close | -0.51 | -0.49 | +3.9% |
| May 15, 2026 | Before the open | -0.48 | -0.54 | -12.5% |
| Mar 27, 2026 | Time not confirmed | -0.64 | -1.03 | -61.8% |
| Nov 12, 2025 | Before the open | -1.34 | -2.16 | -61.2% |
| Aug 12, 2025 | Before the open | -1.56 | -2.45 | -57.1% |
| May 12, 2025 | Before the open | -3.04 | -1.50 | +50.7% |
| Mar 10, 2025 | Before the open | -5.14 | -3.56 | +30.7% |
| Nov 14, 2024 | Before the open | -7.68 | -5.12 | +33.3% |
| Aug 6, 2024 | Before the open | -10.99 | -3.36 | +69.4% |
| May 9, 2024 | Before the open | -0.70 | -0.87 | -24.3% |
| Mar 12, 2024 | Before the open | -12.72 | -12.16 | +4.4% |
| Nov 14, 2023 | Before the open | -20.00 | -25.32 | -26.6% |
| Aug 14, 2023 | Before the open | -27.68 |
BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. It also develops its…
| -29.28 |
| -5.8% |
| May 8, 2023 | Before the open | -1.62 | -1.84 | -13.6% |
| Mar 9, 2023 | Before the open | -22.61 | -31.20 | -38.0% |
| Nov 10, 2022 | Before the open | -20.84 | -23.84 | -14.4% |
| Aug 9, 2022 | Before the open | -18.89 | -21.60 | -14.3% |
| May 9, 2022 | Before the open | -1.15 | -1.12 | +2.6% |
| Mar 10, 2022 | Before the open | -16.21 | -14.88 | +8.2% |
| Nov 10, 2021 | Before the open | -16.56 | -15.36 | +7.2% |
| Aug 10, 2021 | Before the open | -16.75 | -17.76 | -6.0% |
| May 10, 2021 | Before the open | -15.80 | -17.28 | -9.4% |
| Mar 11, 2021 | Before the open | -0.96 | -0.87 | +9.4% |
| Nov 12, 2020 | Before the open | -12.64 | -17.12 | -35.4% |
| Aug 14, 2020 | Before the open | -12.53 | -16.96 | -35.4% |
| May 12, 2020 | Before the open | -9.73 | -12.64 | -29.9% |
| Mar 9, 2020 | Before the open | -0.63 | -0.45 | +28.6% |
| Nov 14, 2019 | Before the open | -9.60 | -9.12 | +5.0% |
| Aug 6, 2019 | Before the open | -9.66 | -8.64 | +10.6% |
| May 7, 2019 | Before the open | -8.50 | -7.36 | +13.4% |
| Mar 7, 2019 | Before the open | -0.39 | -0.46 | -17.9% |
| Nov 9, 2018 | Before the open | -4.61 | -4.96 | -7.6% |
| Aug 8, 2018 | After the close | -4.90 | -3.04 | +38.0% |
| May 14, 2018 | After the close | -4.26 | -5.92 | -39.0% |
| Mar 12, 2018 | After the close | 0.00 | -0.06 | — |